U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.1744A>T (p.Thr582Ser) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 4, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002282828.2

Allele description [Variation Report for NM_000492.4(CFTR):c.1744A>T (p.Thr582Ser)]

NM_000492.4(CFTR):c.1744A>T (p.Thr582Ser)

Gene:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1744A>T (p.Thr582Ser)
HGVS:
  • NC_000007.14:g.117590417A>T
  • NG_016465.4:g.129634A>T
  • NM_000492.4:c.1744A>TMANE SELECT
  • NP_000483.3:p.Thr582Ser
  • NP_000483.3:p.Thr582Ser
  • LRG_663t1:c.1744A>T
  • LRG_663:g.129634A>T
  • LRG_663p1:p.Thr582Ser
  • NC_000007.13:g.117230471A>T
  • NM_000492.3:c.1744A>T
Protein change:
T582S
Links:
dbSNP: rs397508292
NCBI 1000 Genomes Browser:
rs397508292
Molecular consequence:
  • NM_000492.4:c.1744A>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002570622Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(May 4, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Gender-sensitive association of CFTR gene mutations and 5T allele emerging from a large survey on infertility.

Morea A, Cameran M, Rebuffi AG, Marzenta D, Marangon O, Picci L, Zacchello F, Scarpa M.

Mol Hum Reprod. 2005 Aug;11(8):607-14. Epub 2005 Aug 26.

PubMed [citation]
PMID:
16126774

Quantitative methods for the analysis of CFTR transcripts/splicing variants.

Amaral MD, Clarke LA, Ramalho AS, Beck S, Broackes-Carter F, Rowntree R, Mouchel N, Williams SH, Harris A, Tzetis M, Steiner B, Sanz J, Gallati S, Nissim-Rafinifa M, Kerem B, Hefferon T, Cutting GR, Goina E, Pagani F.

J Cyst Fibros. 2004 Aug;3 Suppl 2:17-23. Review.

PubMed [citation]
PMID:
15463919
See all PubMed Citations (8)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002570622.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

Variant summary: CFTR c.1744A>T (p.Thr582Ser) results in a conservative amino acid change located in the ABC transporter-like, ATP-binding domain (IPR003439) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 250028 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1744A>T has been reported in an individual with bronchiectasis as well as an individual with CBAVD, however, both individuals were pancreatic sufficient, had sweat chloride levels greater than 60 mmol/L, and a second CFTR allele was not identified in either case (Cystic Fibrosis Mutation Database). Additionally, in the literature, the variant has been reported in the heterozygous state in infertile patients (Chamayou_2019, Chamayou_2020), but was also reported in controls (Morea_2005). These reports therefore do not provide unequivocal conclusions about association of the variant with Cystic Fibrosis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 15463919, 32357917, 31848897, 35913788, 25880441, 16126774, 25735457, 26277102). Two other submitters have provided clinical-significance assessments for this variant in ClinVar (evaluation after 2014) and both classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024